Clinical Trial Update: Bioequivalence Study of Paclitaxel Protein-bound Particles for Injectable Suspension (Albumin-bound) in Breast Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of nab-paclitaxel (paclitaxel protein-bound particles for injectable suspension, albumin-bound) in breast cancer patients; currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)

Snippet

Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | Conditions: Bioequivalence | Phase 1 | Status: RECRUITING